Literature DB >> 21441786

Analytical methods for physicochemical characterization of antibody drug conjugates.

Aditya Wakankar1, Yan Chen, Yatin Gokarn, Fredric S Jacobson.   

Abstract

Antibody-drug conjugates (ADCs), formed through the chemical linkage of a potent small molecule cytotoxin (drug) to a monoclonal antibody, have more complex and heterogeneous structures than the corresponding antibodies. This review describes the analytical methods that have been used in their physicochemical characterization. The selection of the most appropriate methods for a specific ADC is heavily dependent on the properties of the linker, the drug, and the choice of attachment sites (lysines, inter-chain cysteines, Fc glycans). Improvements in analytical techniques such as protein mass spectrometry and capillary electrophoresis have significantly increased the quality of information that can be obtained for use in product and process characterization, and for routine lot release and stability testing.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21441786      PMCID: PMC3092617          DOI: 10.4161/mabs.3.2.14960

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  52 in total

Review 1.  Arming antibodies: prospects and challenges for immunoconjugates.

Authors:  Anna M Wu; Peter D Senter
Journal:  Nat Biotechnol       Date:  2005-09       Impact factor: 54.908

Review 2.  Heterogeneity of monoclonal antibodies revealed by charge-sensitive methods.

Authors:  J Vlasak; R Ionescu
Journal:  Curr Pharm Biotechnol       Date:  2008-12       Impact factor: 2.837

3.  Immunoconjugates containing novel maytansinoids: promising anticancer drugs.

Authors:  R V Chari; B A Martell; J L Gross; S B Cook; S A Shah; W A Blättler; S J McKenzie; V S Goldmacher
Journal:  Cancer Res       Date:  1992-01-01       Impact factor: 12.701

Review 4.  Assessing monoclonal antibody product quality attribute criticality through clinical studies.

Authors:  Andrew M Goetze; Matthew R Schenauer; Gregory C Flynn
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

5.  Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachment.

Authors:  Charlotte F McDonagh; Eileen Turcott; Lori Westendorf; Jennifer B Webster; Stephen C Alley; Kristine Kim; Jamie Andreyka; Ivan Stone; Kevin J Hamblett; Joseph A Francisco; Paul Carter
Journal:  Protein Eng Des Sel       Date:  2006-04-27       Impact factor: 1.650

6.  Selection of reaction additives used in the preparation of monomeric antibody-calicheamicin conjugates.

Authors:  Irwin Hollander; Arthur Kunz; Philip R Hamann
Journal:  Bioconjug Chem       Date:  2007-11-10       Impact factor: 4.774

7.  Preparation and characterization of monoclonal antibody conjugates of the calicheamicins: a novel and potent family of antitumor antibiotics.

Authors:  L M Hinman; P R Hamann; R Wallace; A T Menendez; F E Durr; J Upeslacis
Journal:  Cancer Res       Date:  1993-07-15       Impact factor: 12.701

8.  Development of potent monoclonal antibody auristatin conjugates for cancer therapy.

Authors:  Svetlana O Doronina; Brian E Toki; Michael Y Torgov; Brian A Mendelsohn; Charles G Cerveny; Dana F Chace; Ron L DeBlanc; R Patrick Gearing; Tim D Bovee; Clay B Siegall; Joseph A Francisco; Alan F Wahl; Damon L Meyer; Peter D Senter
Journal:  Nat Biotechnol       Date:  2003-06-01       Impact factor: 54.908

9.  Therapeutic potential of CD22-specific antibody-targeted chemotherapy using inotuzumab ozogamicin (CMC-544) for the treatment of acute lymphoblastic leukemia.

Authors:  J F Dijoseph; M M Dougher; D C Armellino; D Y Evans; N K Damle
Journal:  Leukemia       Date:  2007-07-26       Impact factor: 11.528

Review 10.  Potent antibody drug conjugates for cancer therapy.

Authors:  Peter D Senter
Journal:  Curr Opin Chem Biol       Date:  2009-05-04       Impact factor: 8.822

View more
  62 in total

1.  Microscale screening of antibody libraries as maytansinoid antibody-drug conjugates.

Authors:  Kalli C Catcott; Molly A McShea; Carl Uli Bialucha; Kathy L Miller; Stuart W Hicks; Parmita Saxena; Thomas G Gesner; Mikias Woldegiorgis; Megan E Lewis; Chen Bai; Michael S Fleming; Seth A Ettenberg; Hans K Erickson; Nicholas C Yoder
Journal:  MAbs       Date:  2016-01-11       Impact factor: 5.857

Review 2.  Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability.

Authors:  Satish K Singh; Donna L Luisi; Roger H Pak
Journal:  Pharm Res       Date:  2015-05-19       Impact factor: 4.200

3.  Utility of Ion Mobility Mass Spectrometry for Drug-to-Antibody Ratio Measurements in Antibody-Drug Conjugates.

Authors:  Richard Y-C Huang; Ekaterina G Deyanova; David Passmore; Vangipuram Rangan; Shrikant Deshpande; Adrienne A Tymiak; Guodong Chen
Journal:  J Am Soc Mass Spectrom       Date:  2015-06-30       Impact factor: 3.109

4.  Immunogenicity of antibody drug conjugates: bioanalytical methods and monitoring strategy for a novel therapeutic modality.

Authors:  M Benjamin Hock; Karen E Thudium; Montserrat Carrasco-Triguero; Nikolai F Schwabe
Journal:  AAPS J       Date:  2014-11-08       Impact factor: 4.009

Review 5.  Antibody drug conjugates: design and selection of linker, payload and conjugation chemistry.

Authors:  Jessica R McCombs; Shawn C Owen
Journal:  AAPS J       Date:  2015-01-22       Impact factor: 4.009

6.  Localized conformational interrogation of antibody and antibody-drug conjugates by site-specific carboxyl group footprinting.

Authors:  Lucy Yan Pan; Oscar Salas-Solano; John F Valliere-Douglass
Journal:  MAbs       Date:  2016-12-08       Impact factor: 5.857

7.  Quantitative collision-induced unfolding differentiates model antibody-drug conjugates.

Authors:  Yuwei Tian; Jennifer L Lippens; Chawita Netirojjanakul; Iain D G Campuzano; Brandon T Ruotolo
Journal:  Protein Sci       Date:  2018-12-22       Impact factor: 6.725

8.  Automated On-tip Affinity Capture Coupled with Mass Spectrometry to Characterize Intact Antibody-Drug Conjugates from Blood.

Authors:  Ke Sherry Li; Phillip Y Chu; Aimee Fourie-O'Donohue; Neha Srikumar; Katherine R Kozak; Yichin Liu; John C Tran
Journal:  J Am Soc Mass Spectrom       Date:  2018-05-29       Impact factor: 3.109

9.  Assessment of physical stability of an antibody drug conjugate by higher order structure analysis: impact of thiol- maleimide chemistry.

Authors:  Jianxin Guo; Sandeep Kumar; Amarnauth Prashad; Jason Starkey; Satish K Singh
Journal:  Pharm Res       Date:  2014-01-24       Impact factor: 4.200

10.  Site-specific protein transamination using N-methylpyridinium-4-carboxaldehyde.

Authors:  Leah S Witus; Chawita Netirojjanakul; Kanwal S Palla; Ellen M Muehl; Chih-Hisang Weng; Anthony T Iavarone; Matthew B Francis
Journal:  J Am Chem Soc       Date:  2013-11-05       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.